Position in MRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,393,685
-$1,808,420 QoQ
Shares Held
3,319,325
-3.7% QoQ
Ownership
1.29%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 92.98155498482372.ToString("F0")%
Shared 0.ToString("F0")%
None 7.018445015176278.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. MRVI ranks #139 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,393,685 | 3,319,325 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,202,105 | 3,446,802 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $8,276,406 | 2,883,767 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $6,933,663 | 2,877,040 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $5,602,282 | 2,534,971 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,170,222 | 2,233,069 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $22,434,827 | 2,699,739 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $12,317,688 | 1,720,348 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $22,583,316 | 2,604,766 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $18,792,915 | 2,869,148 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $14,262,390 | 1,426,239 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $22,755,771 | 1,830,714 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $35,486,373 | 2,532,932 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $26,131,743 | 1,826,118 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $33,278,505 | 1,303,506 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $80,545,670 | 2,835,117 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $100,273,348 | 2,843,021 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $105,606,978 | 2,520,453 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $125,058,341 | 2,548,051 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $79,782,667 | 1,911,878 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $50,173,813 | 1,407,795 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $744,054 | 26,526 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||